Morgan Stanley »

Bioxcel Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $149k 117k 1.28
2024-03-31 $627k 222k 2.82
2023-12-31 $566k 192k 2.95
2023-09-30 $514k 203k 2.53
2023-06-30 $619k 93k 6.66
2022-12-31 $2.7M 125k 21.48
2022-06-30 $3.0M 227k 13.19
2022-03-31 $4.4M 211k 20.91
2021-06-30 $0 119k 0.00
2020-12-31 $1.0M 22k 46.16
2020-09-30 $777k 18k 43.36
2020-06-30 $387k 7.3k 52.94
2020-03-31 $100k 4.5k 22.35
2019-12-31 $150k 10k 14.66
2019-09-30 $20k 2.7k 7.19
2019-03-31 $24k 2.5k 9.59
2018-12-31 $0 4.1k 0.00
2018-09-30 $73k 5.2k 13.89
2018-06-30 $11k 1.2k 8.89
2018-03-31 $30k 2.9k 10.33